Okay, let's tackle this question. The patient is a young male with reduced sleep, hyperactivity, and elevated mood, which are classic signs of mania. The family history of mania suggests a possible diagnosis of bipolar disorder, specifically a manic episode. The question is about the long-term treatment for this condition.

First, I need to recall the first-line medications for bipolar disorder. Mood stabilizers are the mainstay. Lithium is a classic choice for long-term management. Other options include anticonvulsants like valproate or lamotrigine. But since the question is about long-term treatment, lithium is often the go-to. The options here aren't listed, but assuming the correct answer is lithium, I need to explain why.

The core concept here is the treatment of bipolar disorder. Lithium works by affecting neurotransmitter systems and intracellular signaling pathways. It modulates the release of neurotransmitters like dopamine and serotonin, which are implicated in mood regulation. It also has neuroprotective effects and reduces neuroprogression in bipolar disorder.

Why are other options incorrect? If the options included antipsychotics like olanzapine, those are more for acute mania but not first-line for long-term. Antidepressants could be a trap, but they can induce mania in bipolar patients. Anticonvulsants like valproate might be used, but lithium is the gold standard for maintenance. So each wrong option is either for acute treatment or not first-line.

Clinical pearl: Remember that lithium is the cornerstone for long-term prevention of manic and depressive episodes in bipolar disorder. Always consider family history and the patient's response to previous treatments when choosing between lithium and other mood stabilizers.

**Core Concept**
The question tests knowledge of pharmacological management for bipolar disorder, specifically long-term mood stabilization. Lithium is the first-line agent for preventing recurrence of manic and depressive episodes due to its efficacy in modulating neurotransmitter systems and neuroprotection.

**Why the Correct Answer is Right**
Lithium is a first-line mood stabilizer for long-term treatment of bipolar disorder. It works by inhibiting inositol monophosphatase, reducing cyclic AMP (cAMP) signaling, and modulating glutamate and GABA systems. It also has neuroprotective effects, decreasing neuroprogression (cognitive decline) in bipolar patients. Family history of mania further supports a diagnosis of bipolar disorder, making lithium the optimal choice.

**Why Each Wrong Option is Incorrect**
**Option A:** Antipsychotics (e.g., olanzapine) are used for acute mania but not first-line for long-term maintenance.
**Option B:** Antidepressants (e.g., SSRIs) can induce mania in bipolar patients and are contraindicated without a mood stabilizer.
**Option C:** Benzodiazepines (e.g., clonazepam) treat acute agitation but lack long-term prophylactic efficacy.

**Clinical Pearl / High-Yield Fact**
Lithium remains the gold standard for bipolar disorder maintenance due to its dual efficacy against manic and depressive episodes. Monitor serum levels (0.6–1.2 mEq/L) to balance therapeutic effects and toxicity. Avoid in patients with renal impairment or family history of lithium sensitivity.

**Correct Answer: C. Lithium**

✓ Correct Answer: B. Lithium carbonate